PERSANTINE TAB 50MG 50 MG
DIPYRIDAMOLE : 50 MG · DIN 00067393 · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Health Canada status: CANCELLED POST MARKET
What is PERSANTINE TAB 50MG?
PERSANTINE TAB 50MG 50 MG contains DIPYRIDAMOLE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00067393, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Mar-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PERSANTINE TAB 50MG used for?
Prevention of post-operative thromboembolic complications with prosthetic heart valves; induction of pharmacologic vasodilation for myocardial perfusion imaging.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00067393 |
|---|---|
| Brand name | PERSANTINE TAB 50MG |
| Generic / active ingredient | DIPYRIDAMOLE : 50 MG |
| Manufacturer | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | B01AC07 DIPYRIDAMOLE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Mar-2011 |
| Original market date | 1966-12-31 00:00:00 |
How is it administered?
Oral: 100 mg q.i.d. 1 hour before meals (max 600 mg/day). IV: 0.142 mg/kg/min infused over 4 minutes (max 60 mg). Dilute at least 1:2 with Dextrose 5%.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature (15-30°C). Protect ampoules from direct light and avoid freezing.
How is it supplied?
Tablets: Bottles of 100. Ampoules: Packages of 5 x 10 mL ampoules.
Contraindications
Hypersensitivity to drug or ingredients. Intravenous administration is not recommended in states of shock or collapse.
Warnings and precautions
IV use: risk of fatal/non-fatal MI, arrhythmias, stroke. Use caution in patients with hypotension, CAD, unstable angina, or bronchial hyperreactivity. Aminophylline should be available.
What can be used instead?
Other Canadian products sharing ATC code B01AC07 DIPYRIDAMOLE. 2 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIPYRIDAMOLE INJECTION, USP | 5 MG | LIQUID | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02244475 |
| PERSANTINE | 5 MG | SOLUTION | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | MARKETED | DIN 00637734 |
| APO-DIPYRIDAMOLE | 100 MG | TABLET | APOTEX INC | CANCELLED PRE MARKET | DIN 02220571 |
| APO-DIPYRIDAMOLE | 25 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895644 |
| APO-DIPYRIDAMOLE | 50 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895652 |
| APO-DIPYRIDAMOLE | 75 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00895660 |
| APO-DIPYRIDAMOLE-SC TAB 25MG | 25 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00571237 |
| APO-DIPYRIDAMOLE-SC TAB 50MG | 50 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00571245 |
| APO-DIPYRIDAMOLE-SC TAB 75MG | 75 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | DIN 00601845 |
| DIPYRIDAMOLE 25 TAB 25MG | 25 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00579580 |
Who else supplies DIPYRIDAMOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DIPYRIDAMOLE appears in 15 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.